LEADER 04102nam 2200937z- 450 001 9910557748703321 005 20231214132820.0 035 $a(CKB)5400000000045855 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76656 035 $a(EXLCZ)995400000000045855 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiocomposite Inks for 3D Printing 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (213 p.) 311 $a3-0365-1738-3 311 $a3-0365-1737-5 330 $aThree-dimensional (3D) printing has evolved massively during the last years. The 3D printing technologies offer various advantages, including: i) tailor-made design, ii) rapid prototyping, and iii) manufacturing of complex structures. Importantly, 3D printing is currently finding its potential in tissue engineering, wound dressings, tissue models for drug testing, prosthesis, and biosensors, to name a few. One important factor is the optimized composition of inks that can facilitate the deposition of cells, fabrication of vascularized tissue and the structuring of complex constructs that are similar to functional organs. Biocomposite inks can include synthetic and natural polymers, such as poly (?-caprolactone), polylactic acid, collagen, hyaluronic acid, alginate, nanocellulose, and may be complemented with cross-linkers to stabilize the constructs and with bioactive molecules to add functionality. Inks that contain living cells are referred to as bioinks and the process as 3D bioprinting. Some of the key aspects of the formulation of bioinks are, e.g., the tailoring of mechanical properties, biocompatibility and the rheological behavior of the ink which may affect the cell viability, proliferation, and cell differentiation.The current Special Issue emphasizes the bio-technological engineering of novel biocomposite inks for various 3D printing technologies, also considering important aspects in the production and use of bioinks. 606 $aInformation technology industries$2bicssc 610 $abacteria biofabrication 610 $a3D printing 610 $atissue engineering 610 $aprobiotic food 610 $apine sawdust 610 $asoda ethanol pulping 610 $ananocellulose 610 $acytotoxicity 610 $aabsorption 610 $awound dressings 610 $abioprinting 610 $acellulose 610 $ahydrogel 610 $aphysical cross-linking 610 $a3D bioprinting 610 $abiocomposite ink 610 $atubular tissue 610 $atubular organ 610 $abacterial nanocellulose 610 $acellulose nanofibrils 610 $acellulose nanocrystals 610 $abioink 610 $acollagen 610 $aECM 610 $aextracellular matrix 610 $abioinks 610 $abiomanufacturing 610 $abiocomposite 610 $aforest-based MFC 610 $afibrils 610 $aadditive manufacturing 610 $aartificial limb 610 $afused deposition modeling (FDM) 610 $abiofabrication 610 $ahydrogels 610 $agrowth factor cocktail 610 $abioactive scaffold 610 $aprintability 610 $acarboxylated agarose 610 $afree-standing 610 $ahuman nasal chondrocytes 610 $aclinical translational 610 $apolyhydroxyalkanoates 610 $ascaffolds 610 $abiomedicine 610 $adrug delivery 610 $avessel stenting 610 $acancer 610 $a3D cell culture 610 $aCNF 610 $acancer stemness 615 7$aInformation technology industries 700 $aCarrasco$b Gary$4edt$01278408 702 $aCarrasco$b Gary$4oth 906 $aBOOK 912 $a9910557748703321 996 $aBiocomposite Inks for 3D Printing$93013232 997 $aUNINA